A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MDMA / 3,4-methylenedioxymethamphetamine

[Related PubMed/MEDLINE]
Total Number of Papers: 1679
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MDMA  (>> Co-occurring Abbreviation)
Long Form:   3,4-methylenedioxymethamphetamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A case of intoxication with a new cathinone derivative alpha-PiHP - A presentation of concentrations in biological specimens. 4-CMC, alpha-PiHP, NPS
2020 A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. ROI, rs-fMRI
2020 A retrospective of prevalence of drugs of abuse by hair analysis in Shanghai using LC-MS/MS. 5-MeO-DIPT, AFS, AMP, ATS, COC, MA, MDA, THC
2020 Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naive and Cocaine-Exposed Mice. 7,8-DHF, BDNF, OFC, TRKB
2020 Amphetamine and methamphetamine poisonings attended in hospital emergency departments: clinical features and the usefulness of laboratory confirmation. AMP, GC-MS, MAMP
2020 Bucladesine Attenuates Spatial Learning and Hippocampal Mitochondrial Impairments Induced by 3, 4-Methylenedioxymethamphetamine (MDMA). cAMP, MMP, ROS
2020 Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. ---
2020 Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs. MA, TAAR1
2020 Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. LSD
10  2020 Dose concentration and spatial memory and brain mitochondrial function association after 3,4-methylenedioxymethamphetamine (MDMA) administration in rats. CSF, i.p, MWM
11  2020 Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. PTSD, RR, SMD
12  2020 Hollow-fibre liquid-phase microextraction and gas chromatography-mass spectrometric determination of amphetamines in whole blood. AMP, FEN, GC-MS, MDA, MDEA, MET, SWGTOX
13  2020 In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. PTSD
14  2020 Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization. ---
15  2020 Monitoring Consumption of Common Illicit Drugs in Kuala Lumpur, Malaysia, by Wastewater-Cased Epidemiology. NPSs
16  2020 Numerical Analysis of Time-Dependent Inhibition by MDMA. EM, PRA, QI
17  2020 Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol and eugenol via 4-allylcatechol. ---
18  2020 Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by ()-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia. ---
19  2020 Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder. PTG, PTGI, PTSD
20  2020 Psychedelics and Psychedelic-Assisted Psychotherapy. FDA, LSD, PTSD
21  2020 Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring. ---
22  2020 Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine. CAT, MA, MCAT, MDPV, SPCs
23  2020 The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice. DOPAC, FDA, PTSD
24  2020 Use of a newly-developed portable capillary electrophoresis analyser to detect drugs of abuse in oral fluid: A case study. AMP, CE, COC, COET, DOA, FD, HPLC-ESI-MS, MDA, MDEA, METH, OF
25  2019 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and alpha2-adrenergic receptors. 2-AI, MDAI, MMAI, SERT
26  2019 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats. PTSD
27  2019 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth. ARYS, CI
28  2019 8-OH-DPAT Induces Compulsive-like Deficit in Spontaneous Alternation Behavior: Reversal by MDMA but Not Citalopram. 5-HT1AR, SAB
29  2019 A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA. AMPH, ASR, DD
30  2019 A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy. PTSD
31  2019 Adverse pharmacokinetic interactions between illicit substances and clinical drugs. ---
32  2019 Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats. PET, SERT
33  2019 Binge ethanol and MDMA combination exacerbates HSP27 and Trx-1 (biomarkers of toxic cardiac effects) expression in right ventricle. DID, HSP27, TH, Trx-1
34  2019 Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. BTD, FDA, MAPS, PTSD
35  2019 Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose. ---
36  2019 Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example. CBCT, PTSD
37  2019 Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity. VMAT2
38  2019 Determination of amphetamine-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry. AMP, GC-MS, MAMP, MDA, MDE, MEPS, RE
39  2019 Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs™ and application to real samples. 6-MAM, BZE, DOA, FS, MDA, MDEA, OF, THC
40  2019 Dexmedetomidine to Treat 3, 4-Methylenedioxymethamphetamine-Induced Agitation in a 13-Month-Old Infant: A Case Report and Literature Review. ---
41  2019 Distinct neural mechanisms for the prosocial and rewarding properties of MDMA. ---
42  2019 Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of methylenedioxymethamphetamine. AMPH, DA
43  2019 Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017. DC
44  2019 Ecstasy induced acute systolic heart failure and Non-Ischemic Cardiomyopathy in a young female: a rare case report and literature review. ---
45  2019 Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats. FR-20, SERT
46  2019 Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study. ADHD, AUC, HPA, LSD
47  2019 Effects of MDMA on attention to positive social cues and pleasantness of affective touch. ASD, EMG, EOG, MA, PTSD
48  2019 Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice. AD
49  2019 Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults. ---
50  2019 First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants. ---
51  2019 Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. CI, ED
52  2019 Greater empathy in MDMA users. ---
53  2019 Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats. NeuN, NO, RNS, ROS
54  2019 Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age. CTX, KO, NAc, Rhes, SNc, STR, VTA, WT
55  2019 Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival. EDM, GHB, NPS
56  2019 Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine. 4-MMC
57  2019 Long-term systemic administration with low dose of 3,4-methylenedioxymethamphetamine causes photoreceptor cell damage in CD1 mice. ERG
58  2019 MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma. ---
59  2019 MDMA Induced Cardio-toxicity and Pathological Myocardial Effects: A Systematic Review of Experimental Data and Autopsy Findings. ---
60  2019 MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials. ---
61  2019 Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. MDPV
62  2019 Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts. alpha-PVP, MDPV
63  2019 Multi-residue method for enantioseparation of psychoactive substances and beta blockers by gas chromatography-mass spectrometry. ALP, AMP, EF, GC-MS, LOD, LOQ, MAMP, MET, NFLX, PAR, SER
64  2019 Multivisceral Failure in a Context of Serotonin Syndrome Induced by MDMA: The Investigation of a Unique and Nationwide Network. ---
65  2019 Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. DA, LSD, mPFC, NAc, PPI
66  2019 Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR. 3,4-DMAR, direx, 4,4'-DMAR, 4-MAR, DA, HEK, NE, NPS
67  2019 Psychostimulant use and the brain. ---
68  2019 Quantitative Estimation of 38 Illicit Psychostimulants in Blood by GC-APCI-QTOFMS with Nitrogen Chemiluminescence Detection Based on Three External Calibrators. CV, LOQ
69  2019 Rapid and sensitive capillary electrophoresis method for the analysis of Ecstasy in an oral fluid. BGE, CE, MDA, MDEA, OF
70  2019 Rapid and simple analysis of amphetamine-type illegal drugs using excitation-emission matrix fluorescence coupled with parallel factor analysis. MAM
71  2019 Receptor-Enriched Analysis of functional connectivity by targets (REACT): Anovel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA. FC, REACT
72  2019 Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. NEO-PI-R
73  2019 Regional changes in ∆FosB expression in rat brain following MDMA self-administration predict increased sensitivity to effects of locally infused MDMA. ---
74  2019 Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice. AMPA, CNQX, NMDA
75  2019 Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects. SNPs
76  2019 Seizures of ClandestinelyProduced Tablets in Santa Catarina, Brazil: The Increase in NPS from 2011 to 2017. ---
77  2019 Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA). ---
78  2019 Substance-Linked Sex in Heterosexual, Homosexual, and Bisexual Men and Women: An Online, Cross-Sectional "Global Drug Survey" Report. SLS
79  2019 The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa. UCP1
80  2019 The Stimulating Nature of Gambling Behaviors: Relationships Between Stimulant Use and Gambling Among Adolescents. ---
81  2019 The use of wastewater analysis in forensic intelligence: drug consumption comparison between Sydney and different European cities. ---
82  2019 Wastewater-based monitoring of illicit drug consumption in Istanbul: Preliminary results from two districts. AMP, COC, METH
83  2019 [High-risk drug use: epidemiological pattern through hair testing in the forensic context]. AP, MA, MDA, MDEA
84  2019 [Neurotrophic mechanisms of psychedelic therapy]. BDNF, GDNF, LSD, PTSD
85  2019 [Party drugs : when  recreation  rhymes with  consultation ]. GHB, LSD
86  2018 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition. DA, DAT, DHbetaE, SNpc
87  2018 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. PTSD
88  2018 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. ---
89  2018 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Intoxication in a Young Adult with Giant Coronary Aneurysms from Kawasaki Disease. ---
90  2018 3,4-Methylenedioxymethamphetamine causes cytotoxicity on 661W cells through inducing macrophage polarization. ---
91  2018 3,4-Methylenedioxymethamphetamine, mephedrone, and beta-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake. beta-PEA, MPH
92  2018 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. ---
93  2018 Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys. WASO
94  2018 Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice. nAChRs, PA
95  2018 Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. IA, MS, NPS
96  2018 Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy. CI
97  2018 An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users. ---
98  2018 Application of gas chromatography-tandem mass spectrometry for the determination of amphetamine-type stimulants in blood and urine. LLE, MDA, MDEA, MRM
99  2018 Are ecstasy induced serotonergic alterations overestimated for the majority of users? ---
100  2018 Biotic phase micropollutant distribution in horizontal sub-surface flow constructed wetlands. HSSF